Bulk milk testing for foot-and-mouth disease in Australia is economically justified primarily for post-outbreak surveillance or when entry probability is high.
Answers are grounded in this paper and cite their sources.
BMT for FMD may be justified only at high entry risk or low cost; leaves optimal surveillance strategies open for modeling.
Previous foot-and-mouth disease (FMD) outbreaks and simulation-based analyses suggest substantial payoffs from detecting an incursion early. However, no economic measures for early detection have been analysed in an optimising framework. We investigate the use of bulk milk testing (BMT) for active surveillance against an FMD incursion in Australia. We find that BMT can be justified, but only when the FMD entry probability is sufficiently high or the cost of BMT is low. However, BMT is well suited for post-outbreak surveillance, to shorten the length of time and size of an epidemic and to facilitate an earlier return to market.
No takes yet. Share an insight, caveat, or question.
Kompas et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: